Mitochondria in Diabetic Kidney Disease

Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) in the USA. The pathogenesis of DKD is multifactorial and involves activation of multiple signaling pathways with merging outcomes including thickening of the basement membrane, podocyte loss, mesangial expansion, t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amna Ayesha Ahmad, Shayna Odeal Draves, Mariana Rosca
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/fa1ef0bc8b8341198e53cc208d328531
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa1ef0bc8b8341198e53cc208d328531
record_format dspace
spelling oai:doaj.org-article:fa1ef0bc8b8341198e53cc208d3285312021-11-25T17:09:34ZMitochondria in Diabetic Kidney Disease10.3390/cells101129452073-4409https://doaj.org/article/fa1ef0bc8b8341198e53cc208d3285312021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2945https://doaj.org/toc/2073-4409Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) in the USA. The pathogenesis of DKD is multifactorial and involves activation of multiple signaling pathways with merging outcomes including thickening of the basement membrane, podocyte loss, mesangial expansion, tubular atrophy, and interstitial inflammation and fibrosis. The glomerulo-tubular balance and tubule-glomerular feedback support an increased glomerular filtration and tubular reabsorption, with the latter relying heavily on ATP and increasing the energy demand. There is evidence that alterations in mitochondrial bioenergetics in kidney cells lead to these pathologic changes and contribute to the progression of DKD towards ESRD. This review will focus on the dialogue between alterations in bioenergetics in glomerular and tubular cells and its role in the development of DKD. Alterations in energy substrate selection, electron transport chain, ATP generation, oxidative stress, redox status, protein posttranslational modifications, mitochondrial dynamics, and quality control will be discussed. Understanding the role of bioenergetics in the progression of diabetic DKD may provide novel therapeutic approaches to delay its progression to ESRD.Amna Ayesha AhmadShayna Odeal DravesMariana RoscaMDPI AGarticlediabetesdiabetic kidney diseasemitochondriabioenergeticsredox statusBiology (General)QH301-705.5ENCells, Vol 10, Iss 2945, p 2945 (2021)
institution DOAJ
collection DOAJ
language EN
topic diabetes
diabetic kidney disease
mitochondria
bioenergetics
redox status
Biology (General)
QH301-705.5
spellingShingle diabetes
diabetic kidney disease
mitochondria
bioenergetics
redox status
Biology (General)
QH301-705.5
Amna Ayesha Ahmad
Shayna Odeal Draves
Mariana Rosca
Mitochondria in Diabetic Kidney Disease
description Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) in the USA. The pathogenesis of DKD is multifactorial and involves activation of multiple signaling pathways with merging outcomes including thickening of the basement membrane, podocyte loss, mesangial expansion, tubular atrophy, and interstitial inflammation and fibrosis. The glomerulo-tubular balance and tubule-glomerular feedback support an increased glomerular filtration and tubular reabsorption, with the latter relying heavily on ATP and increasing the energy demand. There is evidence that alterations in mitochondrial bioenergetics in kidney cells lead to these pathologic changes and contribute to the progression of DKD towards ESRD. This review will focus on the dialogue between alterations in bioenergetics in glomerular and tubular cells and its role in the development of DKD. Alterations in energy substrate selection, electron transport chain, ATP generation, oxidative stress, redox status, protein posttranslational modifications, mitochondrial dynamics, and quality control will be discussed. Understanding the role of bioenergetics in the progression of diabetic DKD may provide novel therapeutic approaches to delay its progression to ESRD.
format article
author Amna Ayesha Ahmad
Shayna Odeal Draves
Mariana Rosca
author_facet Amna Ayesha Ahmad
Shayna Odeal Draves
Mariana Rosca
author_sort Amna Ayesha Ahmad
title Mitochondria in Diabetic Kidney Disease
title_short Mitochondria in Diabetic Kidney Disease
title_full Mitochondria in Diabetic Kidney Disease
title_fullStr Mitochondria in Diabetic Kidney Disease
title_full_unstemmed Mitochondria in Diabetic Kidney Disease
title_sort mitochondria in diabetic kidney disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/fa1ef0bc8b8341198e53cc208d328531
work_keys_str_mv AT amnaayeshaahmad mitochondriaindiabetickidneydisease
AT shaynaodealdraves mitochondriaindiabetickidneydisease
AT marianarosca mitochondriaindiabetickidneydisease
_version_ 1718412690027708416